Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
autologous adipose-derived stromal vascular fraction + platelet-rich plasma (a06460)
- Development stage
- Unknown
- Lead developer
- Laboratory of Stem Cell Research and Application
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intraarticular
01
Overview
This investigational autologous cell therapy, developed by the Laboratory of Stem Cell Research and Application at the University of Science Ho Chi Minh City, consists of a combination of adipose-derived stromal vascular fraction (SVF) and platelet-rich plasma (PRP). The SVF, which contains a heterogeneous population of cells including mesenchymal stem cells, is isolated from the patient's own adipose tissue (typically from the abdominal area), while the PRP is prepared from their peripheral blood. The therapy is administered via intra-articular injection to treat grade 2-3 knee osteoarthritis. It aims to promote cartilage regeneration and modulate inflammation through the combined action of stem cells and various growth factors released by the activated platelets.
- Other names
- AD-SVF + PRPAutologous adipose stem cells and PRPSVF + PRP
Beyond the preview
Go deeper on autologous adipose-derived stromal vascular fraction + platelet-rich plasma (a06460).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on autologous adipose-derived stromal vascular fraction + platelet-rich plasma (a06460).